Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has granted orphan drug designation to DPTX3186, an investigational remedy being developed by Dewpoint Therapeutics...
On Sept. 5, 2025, the U.S. Meals and Drug Administration (FDA) accepted Inlexzo (gemcitabine intravesical system) for adults with Bacillus Calmette-Guérin (BCG)-unresponsive...
The remedy panorama for sufferers who expertise development after preliminary remedy for smooth tissue sarcomas continues to evolve, in accordance with Dr....
